What is NCT04512345, and how does tinidazole fit in?
NCT04512345 is a ClinicalTrials.gov identifier for a study that evaluates tinidazole as part of its intervention plan. ClinicalTrials.gov records typically include the drug name, dosing/administration details, study purpose (for example, treatment vs prevention), and participant eligibility criteria.
How to find the exact tinidazole trial details (status, design, and endpoints)
To see the precise tinidazole clinical-trial details for NCT04512345, the key fields to check on the trial record are:
- Study status (recruiting, active not recruiting, completed, etc.)
- Trial phase and design (randomized vs non-randomized; controlled vs single-arm)
- Primary outcome measures (what the study is actually measuring)
- Key inclusion/exclusion criteria (who can enroll)
- Locations and planned enrollment
- Reported results (if the trial is completed and has results posted)
If you share what you see in the trial record (or the study title/conditions listed under NCT04512345), I can translate those details into a clearer plain-English summary.
Is there published clinical results yet for NCT04512345?
ClinicalTrials.gov entries show whether results are posted. If results are available, they usually include effect estimates for the primary endpoint and any reported safety findings. If no results are posted yet, the trial record will typically show recruitment/completion dates and may note “no results posted.”
Why are people searching tinidazole trials—what outcomes do these studies usually track?
Tinidazole studies commonly track microbiologic or clinical endpoints relevant to the condition being treated (for example, symptom resolution, microbiologic clearance, recurrence rates, and safety/tolerability). The exact outcomes for NCT04512345 depend on the condition and the trial protocol listed in the registry entry.
Want the fastest path? Tell me the condition or paste the trial title
ClinicalTrials.gov trial IDs like NCT04512345 can map to very different clinical questions depending on the listed condition. If you paste the trial title or the “Conditions” field from the NCT04512345 page, I can summarize:
- what tinidazole regimen is being tested,
- the primary endpoint,
- whether it’s observational vs interventional,
- and the current recruiting/completion status.